CN Patent

CN111448316B — 新的硫代亚磷酰胺

Assigned to Roche Innovation Center Copenhagen AS · Expires 2025-02-14 · 1y expired

What this patent protects

本发明涉及式(II)或(IIb)的化合物，其中X、Y、R x 、R y 、R 5 和Nu如本说明书中和权利要求书中所定义。式(II)的化合物可以用于制造寡核苷酸。

USPTO Abstract

本发明涉及式(II)或(IIb)的化合物，其中X、Y、R x 、R y 、R 5 和Nu如本说明书中和权利要求书中所定义。式(II)的化合物可以用于制造寡核苷酸。

Drugs covered by this patent

Patent Metadata

Patent number
CN111448316B
Jurisdiction
CN
Classification
—
Expires
2025-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Roche Innovation Center Copenhagen AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.